Cambridge, UK, 04 August 2008 - Disease Models & Mechanisms (DMM) is the first journal to focus on translational research and the use of model organisms to advance human health. Published by the Company of Biologists, DMM is a highly anticipated biomedical research journal which officially launched its inaugural issue both in print and online today at http://DMM.biologists.org.
DMM focuses on human disease and the research necessary to develop treatments for illness. The field of translational medicine where basic science research is "translated" into treatments and cures for disease has been growing exponentially, particularly given the recent advances in genomics and life sciences, and shifts in global research funding. DMM aims to fill a niche in translational research by publishing articles about human disease and the model organisms used in biomedical research.
The special inaugural issue features editorial commentary, review articles, and research highlights on topics ranging from cancer detection, to understanding human diseases using flies or worms and the future impact of mouse genetics on humankind. Future issues will include primary research articles, and DMM continues to invite authors to submit articles which focus on human disease. Interviews and Podcasts focusing on areas of special interest will become regular features.
DMM's founders believe that the journal will provide a community forum for clinicians and scientists to discuss their findings and observations. DMM's Editor-in-Chief, Vivian Siegel, invites students, fellows, policymakers, clinicians, and scientists to "use the journal and its website to share resources and discoveries".
In addition to its publishing goals, the journal is committed to assisting early-career scientists by offering travelling fellowships to graduate students and postdoctoral fe
|Contact: Donna Perry|
The Company of Biologists